KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Globus Medical (GMED) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Globus Medical (GMED) over the last 15 years, with Q3 2025 value amounting to $252.5 million.

  • Globus Medical's Cost of Revenue fell 664.73% to $252.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $960.1 million, marking a year-over-year decrease of 745.97%. This contributed to the annual value of $1.0 billion for FY2024, which is 8889.6% up from last year.
  • Globus Medical's Cost of Revenue amounted to $252.5 million in Q3 2025, which was down 664.73% from $248.8 million recorded in Q2 2025.
  • In the past 5 years, Globus Medical's Cost of Revenue ranged from a high of $270.5 million in Q3 2024 and a low of $55.0 million during Q1 2021
  • For the 5-year period, Globus Medical's Cost of Revenue averaged around $146.5 million, with its median value being $76.5 million (2023).
  • Per our database at Business Quant, Globus Medical's Cost of Revenue surged by 27609.04% in 2023 and then crashed by 1908.59% in 2025.
  • Over the past 5 years, Globus Medical's Cost of Revenue (Quarter) stood at $61.8 million in 2021, then increased by 14.23% to $70.6 million in 2022, then soared by 276.09% to $265.5 million in 2023, then dropped by 0.77% to $263.4 million in 2024, then dropped by 4.14% to $252.5 million in 2025.
  • Its Cost of Revenue was $252.5 million in Q3 2025, compared to $248.8 million in Q2 2025 and $195.4 million in Q1 2025.